Selectis Health, Inc. (GBCS) Stock Price & Analysis
Selectis Health, Inc. (GBCS) rose 0.00% to USD 3.1 as of June 10, 2026 at 13:03 UTC, according to Nexqual real-time market data.
GBCS last closed at USD 3.1; the session ranged USD 3.1–3.1 on volume of 16 shares. Market capitalization is $9.51M, with a 52-week range of USD 0.41–4.58 (OQB). Source: Nexqual, June 10, 2026 at 13:03 UTC.
Key Statistics (as of June 10, 2026 at 13:03 UTC)
| Price | USD 3.1 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 3.1 |
| Open | USD 3.1 |
| Day Range | USD 3.1 – 3.1 |
| 52-Week Range | USD 0.41 – 4.58 |
| Volume | 16 shares |
| Market Cap | $9.51M |
| Exchange | OQB |
Technical Analysis (GBCS)
Nexqual's technical model rates GBCS "STRONG SELL" based on 0 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 13:03 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 35.79 (neutral) |
| vs SMA50 | Below (USD 3.79) |
| MACD | -0.21 (negative) |
Analyst Ratings (GBCS)
Wall Street analysts rate GBCS "None", per Nexqual as of June 10, 2026 at 13:03 UTC.
| Consensus Rating | None |
|---|
Earnings (GBCS)
Source: Nexqual, June 10, 2026 at 13:03 UTC.
Financials & Fundamentals (GBCS)
| Total Revenue | $38.24M |
|---|---|
| Revenue Growth (YoY) | -30.50% |
| Gross Margin | +22.22% |
| Operating Margin | -17.32% |
| Profit Margin | +16.13% |
| Debt / Equity | 6,659.41 |
| Current Ratio | 0.6 |
| Total Cash | $1.29M |
| Total Debt | $17.20M |
| Free Cash Flow | $-2.34M |
Source: Nexqual, June 10, 2026 at 13:03 UTC.
Financial Health Score (GBCS)
Nexqual rates Selectis Health, Inc.'s overall financial health "Weak" across five dimensions, as of June 10, 2026 at 13:03 UTC.
| Growth | Critical — Revenue -31% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Critical — $1M cash vs $17M debt |
| Cash Flow | Weak — FCF negative: -$2M, burning cash |
| Efficiency | Mixed — No data |
Ownership (GBCS)
| Insider Ownership | +22.15% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 3.07M |
| Float | 2.39M |
Source: Nexqual, June 10, 2026 at 13:03 UTC.
Leadership (GBCS)
Selectis Health, Inc. is led by Krystal Eckhart (age 40), Interim CEO & CFO and VP of Revenue Management, per Nexqual as of June 10, 2026 at 13:03 UTC.
| Interim CEO & CFO and VP of Revenue Management | Krystal Eckhart (age 40) |
|---|---|
| Vice President of Operations | Sarah Day |
| Director & Legal Counsel | Clifford L. Neuman (age 77) |
From Selectis Health, Inc.'s Latest SEC 10-K Filing (filed 2026-04-15)
Key Strengths & Strategy (as disclosed to the SEC)
- Selectis Health, Inc. owns and operates, through wholly-owned subsidiaries Assisted Living Facilities, Independent Living Facilities, and Skilled Nursing Facilities across the South and Southeastern portions of the US.
- The Company acquires, develops, leases and manages healthcare real estate and provides healthcare operations through our wholly-owned subsidiaries.
- Our portfolio is comprised of investments in the following healthcare operations: (i) senior housing (including independent and assisted living) and (ii) post-acute/skilled nursing.
- We will make investments within our healthcare operations using the following six investment products: (i) direct ownership of properties, (ii) debt investments, (iii) developments and redevelopments, (iv) investment management, (v) the Housing and Economic Recovery Act of 2008 (RIDEA), which represents investments in senior housing operations utilizing the structure permitted by RIDEA and (vi) owning healthcare operations.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TBTC | Table Trac, Inc. | USD 4.37 | ▼ 2.24% |
| BTVRF | BLUERUSH INC. | USD 0 | ▲ 0% |
| EFRMF | EAST AFRICA METALS INC | USD 0.01 | ▲ 0% |
| XTMIF | XTM Inc. | USD 0 | ▲ 0% |
| RENO | Renovare Environmental, Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 13:03 UTC. This page is informational and not investment advice.